The therapeutic potential of an allosteric non-competitive CXCR1/2 antagonist for diabetic nephropathy.
Grasselli C, Bombelli S, D'Esposito V, Di Tolla MF, L'Imperio V, Rocchio F, Miscione MS, Formisano P, Pagni F, Novelli R, Ruffini PA, Aramini A, Allegretti M, Perego R, De Filippis L.
Grasselli C, et al. Among authors: perego r.
Diabetes Metab Res Rev. 2023 Oct;39(7):e3694. doi: 10.1002/dmrr.3694. Epub 2023 Jul 20.
Diabetes Metab Res Rev. 2023.
PMID: 37470287
Free article.